Barchart.com
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Adamas Pharma (ADMS)

Adamas Pharma (ADMS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.22 +0.06 (+0.74%) 11/23/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.22 unch (unch) -
News & Headlines for Tue, Nov 23rd, 2021
Help
Go To:
Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals Globe Newswire - Wed Nov 24, 2021

Acquisition strengthens Parkinson’s disease portfolio and diversifies revenue and cash flow...

SUPN : 31.35 (+1.65%)
ADMS : 8.22 (+0.74%)
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer Globe Newswire - Tue Nov 23, 2021

ROCKVILLE, Md., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that the required waiting period under...

SUPN : 31.35 (+1.65%)
ADMS : 8.22 (+0.74%)
Adamas: Q3 Earnings Snapshot AP - Thu Nov 11, 2021

EMERYVILLE, Calif. (AP) _ Adamas Pharmaceuticals Inc. (ADMS) on Wednesday reported a loss of $19.5 million in its third quarter.

ADMS : 8.22 (+0.74%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the Firm PR Newswire - Thu Oct 28, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: FTS International, Inc. (NYSE:...

FTSI : 26.49 (-0.15%)
ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
UMPQ : 17.66 (-1.73%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations PR Newswire - Tue Oct 26, 2021

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EBMT : 17.29 (+0.93%)
ADMS : 8.22 (+0.74%)
AZPN : 264.33 (+0.01%)
FLXN : 9.12 (-0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, XLRN, ADMS, AZPN; Shareholders are Encouraged to Contact the Firm ACCESS Newswire - Thu Oct 21, 2021

NEW YORK, NY / ACCESSWIRE / October 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Umpqua Holdings Corporation (NASDAQ:UMPQ) concerning...

ADMS : 8.22 (+0.74%)
XLRN : 178.75 (-0.52%)
AZPN : 264.33 (+0.01%)
UMPQ : 17.66 (-1.73%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRA, EBMT, ESBK, ADMS; Shareholders are Encouraged to Contact the Firm PR Newswire - Wed Oct 20, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kraton Corporation (NYSE: KRA)...

EBMT : 17.29 (+0.93%)
ESBK : 23.08 (+0.04%)
ADMS : 8.22 (+0.74%)
KRA : 46.49 (+0.02%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations PR Newswire - Mon Oct 18, 2021

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EBMT : 17.29 (+0.93%)
ADMS : 8.22 (+0.74%)
AZPN : 264.33 (+0.01%)
FLXN : 9.12 (-0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, ACBI, SQ; Shareholders are Encouraged to Contact the Firm PR Newswire - Fri Oct 15, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Adamas Pharmaceuticals, Inc....

ADMS : 8.22 (+0.74%)
ACBI : 32.34 (-0.09%)
FLXN : 9.12 (-0.22%)
SQ : 86.96 (+0.67%)
ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS Business Wire - Tue Oct 12, 2021

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Adamas Pharmaceuticals, Inc. (NasdaqGM: ADMS)...

ADMS : 8.22 (+0.74%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 1 hour ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot